Causes of Recurrent Arterial Thrombosis
Recurrent arterial thrombosis is primarily caused by atherosclerosis, with stroke and coronary heart disease being the main manifestations, and shares common risk factors with venous thrombosis including aging, immobility, and obesity 1.
Primary Pathophysiology
Arterial thrombosis fundamentally differs from venous thrombosis in its underlying mechanism. Atherosclerosis is the main driver of arterial thrombosis 1, resulting from plaque disruption, platelet activation, and coagulation pathway amplification 2. This distinguishes it from venous thromboembolism, which involves different pathophysiologic processes.
Key Risk Factors for Recurrent Arterial Events
Traditional Cardiovascular Risk Factors
The following factors increase risk of recurrent arterial thrombosis:
- Advanced age (particularly >65 years) 3
- Male sex 4
- Smoking
- Arterial hypertension 5
- Obesity and metabolic syndrome 1, 6
- Diabetes mellitus 7
Underlying Cardiovascular Disease
Patients with established arterial disease face heightened recurrence risk:
- Coronary artery disease 6
- Prior stroke or transient ischemic attack 8
- Peripheral artery disease 9, 6
- Atrial fibrillation (embolic source) 9
- Valvular heart disease 9
- Left ventricular thrombus (post-MI or cardiomyopathy) 9
Specific Clinical Scenarios
Acute Limb Ischemia (ALI)
When evaluating recurrent arterial thrombosis presenting as ALI, a comprehensive medical history and physical examination should determine the cause of thrombosis or embolization 9. Key causes include:
- Acute thrombosis of native vessels or bypass grafts in known PAD (most common in patients with prior revascularization, amputation, or ABI ≤0.60) 9
- Arterial embolism from cardiac sources
- Dissection
- Trauma
- Recent vascular access procedures 9
Myeloproliferative Neoplasms
In patients with polycythemia vera or essential thrombocythemia, recurrent arterial thrombosis risk is stratified by:
- Age ≥65 years 7
- Prior thrombosis history 7
- Leukocytosis (confers 60% increased risk in ET, 34% in PV) 7
- JAK2V617F mutation 7
- Cardiovascular risk factors (hypertension, diabetes, smoking) 7
Prothrombotic Conditions
Antiphospholipid Syndrome
Antiphospholipid syndrome is a critical acquired cause of recurrent arterial thrombosis, particularly in younger patients 10. Key features include:
- Triple IgG-aPL positivity (IgG aCL, IgG aβ2GP1, IgG aβ2GP1-D1) increases recurrence risk more than 3-fold 10
- IgG-aPS/PT positivity strongly associates with recurrence (72.6% of recurrent cases) 10
- Recurrent cerebral circulation events are common with arterial involvement 10
- Obesity increases recurrence risk 5-fold in APS patients 10
Hereditary Thrombophilias
Factor V Leiden and prothrombin G20210A mutations are NOT significantly associated with arterial stroke 8. These mutations primarily increase venous thrombosis risk. The evidence shows:
- Majority of case-control studies found no association between Factor V Leiden, prothrombin 20210 mutations, or deficiencies of protein C, protein S, or antithrombin III and arterial stroke 8
- These factors may be relevant only in specific contexts like paradoxical embolism with patent foramen ovale 8
Secondary Thrombocythemia
Ischemia-reperfusion injury can cause secondary thrombocythemia leading to recurrent arterial thrombosis 11. This is characterized by:
- Platelet count positively correlated with tissue injury markers (ALT, AST, LDH, CK)
- Contradictory platelet function test results
- Recurrence at previous thrombosis sites
Malignancy-Associated Thrombosis
Active cancer significantly increases recurrent thrombosis risk (HR 2.64 during anticoagulation) 3. Cancer-associated thrombosis should be considered when:
- Unexplained recurrent events occur
- Thrombosis develops at unusual sites
- Standard anticoagulation fails 12
Rare but Important Causes
When recurrent arterial thrombosis occurs despite anticoagulation, investigate:
- Paroxysmal nocturnal hemoglobinuria 12
- Behçet's disease 12
- COVID-19 infection (recently established association with ALI) 9
- Heparin-induced thrombocytopenia type II (if recurrence on heparin, even with normal platelet counts) 12
Critical Pitfalls
Do not routinely test for Factor V Leiden or prothrombin mutations in arterial thrombosis unless paradoxical embolism is suspected 8
Inadequate anticoagulation is a major cause of recurrence: 38.7% of recurrent cases involved direct oral anticoagulants, 32.5% had non-adherence, and 27.4% occurred despite warfarin therapy 10
Drug interactions and malabsorption can cause sub-therapeutic anticoagulant levels leading to breakthrough events 12
Recent COVID-19 infection should be queried in all ALI presentations 9